Advertisement
Screener

Dianthus Therapeutics, Inc. /DE/ (DNTH) Patents: Active

Dianthus Therapeutics, Inc. /DE/ Active Patents

14 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2023-11-21: Application 18515714; Invention ANTIBODIES THAT BIND TO C1S AND USES THEREOF; Applicant DIANTHUS THERAPEUTICS OPCO, INC.; Status Patented Case.
  • 2022-05-20: Application 17749362; Invention ANTIBODIES THAT BIND TO C1S AND USES THEREOF; Applicant DIANTHUS THERAPEUTICS OpCo, INC.; Status Patented Case.
  • 2020-11-17: Application 16950522; Invention ANTI-CD117 ANTIBODIES AND CONJUGATES; Applicant Magenta Therapeutics, Inc.; Status Patented Case.
  • 2019-09-13: Application 16570045; Invention ARYL HYDROCARBON RECEPTOR ANTAGONISTS AND USES THEREOF; Applicant Magenta Therapeutics Inc.; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2023-11-2118515714ANTIBODIES THAT BIND TO C1S AND USES THEREOFDIANTHUS THERAPEUTICS OPCO, INC.Patented Case2024-10-0812110344US20240166769A1
Vahe Bedian
Charles A. Omer
United States
United States
WEN, SHARON X
2022-05-2017749362ANTIBODIES THAT BIND TO C1S AND USES THEREOFDIANTHUS THERAPEUTICS OpCo, INC.Patented Case2025-03-1812252550US20220380483A1
VAHE BEDIAN
United States
O'BRIEN, LEA S
2020-11-1716950522ANTI-CD117 ANTIBODIES AND CONJUGATESMagenta Therapeutics, Inc.Patented Case2023-02-0711572411US20210317228A1
Bradley R. Pearse
Anthony Boitano
Rahul Palchaudhuri
Sean McDonough
Rajiv Panwar
Jonathan Philip Belk
Matthew Duncan Smith
United States
United States
United States
United States
United States
United States
United States
PUTTLITZ, KARL J
2019-09-1316570045ARYL HYDROCARBON RECEPTOR ANTAGONISTS AND USES THEREOFMagenta Therapeutics Inc.Patented Case2021-02-1610919900US20200123161A1
Arthur Glenn ROMERO
United States
SHAMEEM, GOLAM M
2019-02-2816289388METHODS FOR THE DEPLETION OF CELLSMagenta Therapeutics, Inc.Patented Case2020-04-2110624973US20190192682A1
Andrew Nixon
Dwight Morrow
Adam Hartigan
United States
United States
United States
PUTTLITZ, KARL J
2019-02-0816271376ARYL HYDROCARBON RECEPTOR ANTAGONISTS AND USES THEREOFMagenta Therapeutics Inc.Patented Case2019-07-1610351572US20190177330A1
Arthur Glenn Romero
United States
SHAMEEM, GOLAM M
2018-11-2116198407COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD137+ CELLSMagenta Therapeutics, Inc.Patented Case2019-10-0810434185US20190076548A1
Adam Hartigan
Anthony Boitano
Michael Cooke
Megan D. Hoban
Rahul Palchaudhuri
United States
United States
United States
United States
United States
HUYNH, PHUONG N
2018-10-2316168823COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD117+ CELLSMagenta Therapeutics, Inc.Patented Case2021-01-2610899843US20190153114A1
Bradley R. Pearse
Michael Cooke
Anthony Boitano
Rahul Palchaudhuri
Sean McDonough
Rajiv Panwar
Jacob Glanville
United States
United States
United States
United States
United States
United States
United States
PUTTLITZ, KARL J
2018-10-2316168816COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD117+ CELLSMagenta Therapeutics, Inc.Patented Case2021-01-0510882915US20190144558A1
Bradley R. Pearse
Anthony Boitano
Rahul Palchaudhuri
Sean McDonough
Rajiv Panwar
Jonathan Philip Belk
Matthew Duncan Smith
United States
United States
United States
United States
United States
United States
United States
PUTTLITZ, KARL J
2018-04-1215951585ARYL HYDROCARBON RECEPTOR ANTAGONISTS AND USES THEREOFMagenta Therapeutics Inc.Patented Case2019-10-2910457683US20180298013A1
Arthur Glenn ROMERO
United States
SHAMEEM, GOLAM M
2018-01-1915875793COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD137+ CELLSMagenta Therapeutics, Inc.Patented Case2020-03-0310576161US20180289832A1
Adam Hartigan
Anthony Boitano
Michael Cooke
Megan D. Hoban
Rahul Palchaudhuri
United States
United States
United States
United States
United States
HUYNH, PHUONG N
2017-12-0615834017DOSING REGIMENS FOR THE MOBILIZATION OF HEMATOPOIETIC STEM CELLSMagenta Therapeutics Inc.Patented Case2018-08-2810058573
Dwight Morrow
Patrick C. Falahee
Anthony Boitano
Michael P. Cooke
Kevin A. Goncalves
United States
United States
United States
United States
United States
VISONE, THOMAS J
2015-12-0314895896MODIFIED ANTIBODIES AND RELATED COMPOUNDS, COMPOSITIONS, AND METHODS OF USEMagenta Therapeutics, Inc.Patented Case2020-09-2210781259US20160130349A1
David Jackson
Edward Ha
United States
United States
KOSACK, JOSEPH R
2015-12-0314895893NOVEL LINKERS FOR ANTIBODY-DRUG CONJUGATES AND RELATED COMPOUNDS, COMPOSITIONS, AND METHODS OF USEMagenta Therapeutics, Inc.Patented Case2022-01-2511229711US20160367699A1
David Jackson
Edward Ha
United States
United States
PUTTLITZ, KARL J

Similar stocks

Stock NameCountryMarket CapPE Ratio
Erasca, Inc. (ERAS)United States$5.073B-19.96
PTC THERAPEUTICS, INC. (PTCT)United States$5.199B-177.07
Veradermics, Inc (MANE)United States$4.839B
Gossamer Bio, Inc. (GOSS)United States$5.355B-0.65
Cogent Biosciences, Inc. (COGT)United States$5.450B-17.61
Oruka Therapeutics, Inc. (ORKA)United States$5.663B-43.76
Edgewise Therapeutics, Inc. (EWTX)United States$4.470B-22.23
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10
Mirum Pharmaceuticals, Inc. (MIRM)United States$5.798B-8.81
Viking Therapeutics, Inc. (VKTX)United States$4.287B-8.51